CARLSON CAPITAL L P 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-19 4:05 pm Sale |
2024-11-15 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 124,000 3.450% |
-93,960![]() (-43.11%) |
Filing |
2024-05-08 4:26 pm Purchase |
2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 217,960 9.120% |
144,280![]() (+195.82%) |
Filing |
2023-02-09 4:30 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 73,680 5.100% |
-14,080![]() (-16.04%) |
Filing |
2022-11-28 4:17 pm Purchase |
2022-11-22 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 87,760 6.200% |
87,760![]() (New Position) |
Filing |